BREAST CANCER PANEL-2

What this test checks

An extended breast cancer marker panel that includes additional markers beyond the standard ER/PR/HER2/Ki-67, providing further characterisation of tumour biology for complex cases.

Why do people get this test?

Some breast cancers require additional markers to fully define their biology — particularly for borderline HER2 cases, special histological subtypes, or when planning neo-adjuvant therapy.

When you should consider this test

• When standard breast cancer panel results are equivocal or complex
• When additional tumour characterisation is needed for treatment planning
• For special histological breast cancer subtypes requiring additional markers

How to prepare

No preparation needed — performed on biopsy or surgical tissue.